Decision: Favourable

Study Title:

An open-label, single site, pilot clinical investigation to assess the detectability and sizing of invasive breast cancers, the detectability of benign breast lesions, as well as the differentiation between malignant and benign breast lesions using the Wavelia #2 Microwave Breast Imaging system (Wavelia #2 Pilot #1 Study

  • NREC Code:

    22-NREC-MD-031

  • Decision:

    Favourable

  • Meeting Date:

    13/10/2022

  • Study Type:

    MD application

  • Principal Investigator:

    Prof Michael J Kerin

  • PI Institution:

    Galway University Hospital

  • Sponsor:

    MVG Industries SAS

Scroll to Top